Loading…
Production and evaluation of parathyroid hormone receptor1 ligands with intrinsic or assembled peroxidase domains
Parathyroid hormone (PTH) can be C-terminally extended without significant affinity loss for the PTH 1 receptor (PTHR 1 ). We developed fusion protein ligands with enzymatic activity to probe PTHR 1 s at the cell surface. Two fusion proteins were generated by linking PTH to the N-terminus of either...
Saved in:
Published in: | Scientific reports 2017-10, Vol.7 (1), p.1-14, Article 13099 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Parathyroid hormone (PTH) can be C-terminally extended without significant affinity loss for the PTH
1
receptor (PTHR
1
). We developed fusion protein ligands with enzymatic activity to probe PTHR
1
s at the cell surface. Two fusion proteins were generated by linking PTH to the N-terminus of either horseradish peroxidase (PTH-HRP) or the genetically modified soybean peroxidase APEX2 (PTH-APEX2). Alternatively, myc-tagged PTH (PTH-myc) was combined with antibodies, some of which HRP-conjugated, in the extracellular fluid. The three PTH-fusion proteins were produced as conditioned mediums (CM) by transfected producer HEK 293a cells. Binding of receptor-bound enzymatic ligands was revealed using widely available substrate/co-substrate systems. The stimulation of recipient HEK 293a expressing PTHR
1
s with the PTH-myc/antibodies combination or with PTH-APEX2 supported the histochemical or luminescent detection of recombinant PTHR
1
s (TrueBlue
TM
or luminol-based reagent). The PTH-HRP construction was the most sensitive and supported all tested peroxidase co-substrates (TrueBlue
TM
, tetramethylbenzidine (TMB), luminol, biotin-phenol with streptavidin-Qdots); the 3 latter schemes identified endogenous PTHR
1
in the osteoblastic HOS cell line. The specificity of the fusion protein binding to PTHR
1
was determined by its competition with an excess of PTH
1–34
. Bifunctional ligands possessing enzymatic activity detect intact receptors with various possible applications, including the screening of drugs that compete for receptor binding. |
---|---|
ISSN: | 2045-2322 2045-2322 |
DOI: | 10.1038/s41598-017-13548-0 |